Multifocal motor neuropathy

Journal of Neurology

Volumn 244, Issue 3, 1997, Pages 143-152

  Biessels, Geert Jan ^a   Franssen, Hessel ^a   Van Den Berg, Leonard H ^a   Gibson, Andrew ^b   Kappelle, L Jaap ^a   Venables, Graham S ^b   Wokke, John H J ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

Author keywords

Anti GM1 antibodies; Conduction block; Cyclophosphamide; Human immunoglobulin; Multifocal motor neuropathy

Indexed keywords

CYCLOPHOSPHAMIDE; GANGLIOSIDE ANTIBODY; GANGLIOSIDE GM1; IMMUNOGLOBULIN; IMMUNOMODULATING AGENT;

ANTIBODY TITER; FASCICULATION; FOREARM; HUMAN; MOTOR NEUROPATHY; MUSCLE ATROPHY; MUSCLE WEAKNESS; NERVE BLOCK; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; TENDON;

BIOPSY; CHRONIC DISEASE; COMBINED MODALITY THERAPY; DEMYELINATING DISEASES; DIAGNOSIS, DIFFERENTIAL; HUMANS; LABORATORY TECHNIQUES AND PROCEDURES; MOTOR NEURON DISEASE; NEURAL CONDUCTION;

EID: 0031039102     PISSN: 03405354     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004150050065     Document Type: Review

References (94)

1. Adams D, Kuntzer T, Burger D, Chofflon M, Magistris MR, Regli F, Steck AJ (1991) Predictive value of antiGM1 ganglioside antibodies in neuromusculur diseases: a study of 180 sera. J Neuroimmunol 32: 223-230
2. Adams D, Kuntzer T, Sleek AJ, Lobrinus A, Janzer RC, Regli F (1993) Motor conduction block and high titres of anti-GM1 ganglioside antibodies: pathological evidence of a motor neuropathy in a patient with lower motor neuron syndrome. J Neurol Neurosurg Psychiatry 56: 982-987
3. Ad Hoc Subcommittee of the American Academy of Neurology AIDS Task Force (1991) Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP). Neurology 41: 617-618
4. Auer RN, Bell RB, Lee MA (1989) Neuropathy with onion bulb formations and pure motor manifestations. Can J Neurol Sci 16: 194-197
5. Azulay JP, Blin O, Pougel J, Boucraut J, Bille-Turc F, Carles G (1994) Intravenous immunoglobulin treatment in patients with motor neuron syndromes associated with anti-GM1 antibodies: a double-blind, placebo-controlled study. Neurology 44: 429-432
6. Barohn RJ, Kissel JT, Warmolts JR, Mendell JR (1989) Chronic inflammatory demyelinating polyradiculoneuropathy. Clinical characteristics, course, and recommendations for diagnostic criteria. Arch Neurol 46: 878-884
7. Behnia M, Kelly JJ (1991) Role of electromyography in amyotrophic lateral sclerosis. Muscle Nerve 14: 1236-1241
8. Boss MA, Ananth U, Paquet D, Murphy PD (1995) A retrospective study of 47 patients with highly elevated antiGM1 antibodies. Muscle Nerve 18: 128-129
9. Bouche P, Moulonguet A, Benyouneschennoufi A, Adams D, Baumann N, Meininger V, Leger JM, Said G (1995) Multifocal motor neuropathy with conduction block: a study of 24 patients. J Neurol Neurosurg Psychiatry 59: 38-44
10. Bradley WG (1987) Recent views on amyotrophic lateral sclerosis with emphasis on electrophysiological studies. Muscle Nerve 10: 490-502
11. Chad DA, Hammer K, Sargent J (1986) Slow resolution of multifocal weakness and fasciculation: a reversible motor neuron syndrome. Neurology 36: 1260-1263
12. Chancellor AM, Slattery JM, Fraser H, Swinger RJ, Holloway SM, Warlow CP (1993) The prognosis of adult-onset motor neuron disease: a prospective study based on the Scottish Motor Neuron Disease Register. J Neurol 240: 339-346
13. Chaudhry V, Corse AM, Comblath DR, Kuncl RW, Drachman DB, Freimer MLM, Griffin JW (1993) Multifocal motor neuropathy: response to human immune globulin. Ann Neurol 33: 237-242
14. Chaudhry V, Corse AM, Cornblath DR, Kuncl RW, Freimer ML, Griffin JW (1994) Multifocal motor neuropathy: electrodiagnostic features. Muscle Nerve 17: 198-205
15. Chio A, Brignolio F, Leone M, Mortara P, Rosso MG, Triholo A, Schiffer D (1985) A survival analysis of 155 cases of progressive muscular atrophy. Acta Neurol Scand 72: 407-413
16. Chokroverty S, Deutsch A, Guha C, Gonzalez A, Kwan P, Burger R, Goldberg J (1995) Thoracic spinal nerve and root conduction: a magnetic stimulation study. Muscle Nerve 18: 987-991
17. Comi G, Amadio S, Galardi G, Fazio R, Nemni R (1994) Clinical and neurophysiological assessment of immunoglobulin therapy in five patients with multifocal motor neuropathy. J Neurol Neurosure Psychiatry [Suppl] 57: 35-37
18. Corbo M, Quattrini A, Lugaresi A, Santoro M, Latov N, Hays AP (1992) Patterns of reactivity of human anti-GM1 antibodies with spinal cord and motor neurons. Ann Neurol 32: 487-493
19. Corbo M, Quattrini A, Latov N, Hays AP (1993) Localization of GM1 and Gal(beta 1-3)GalNAc antigenic determinants in peripheral nerve. Neurology 43: 809-814
20. Cornblath DR, Chaudhry V, Griffin JW (1991) Treatment of chronic inflammatory demyelinating polyneuropathy with intravenous immunoglobulin. Ann Neurol 30: 104-106
21. Cornblath DR, Sumner AJ, Daube J, Gilliat RW, Brown WF, Parry GJ, Miller RG, Petajan J (1991) Conduction block in clinical practice. Muscle Nerve 14: 869-871
22. Cornblath DR, Kuncl RW, Mellits ED, Quaskey SA, Clawson L, Pestronk AD (1992) Nerve conduction studies in amyotrophic lateral sclerosis. Muscle Nerve 15: 1111-1115
23. Daube JR (1985) Electrophysiologic studies in the diagnosis and prognosis of motor neuron diseases. Neurol Clin 3: 473-493
24. Donaghy M, Mills KR, Boniface SJ, Simmons J, Wright I, Gregson N. Jacobs J (1994) Pure motor demyelinating neuropathy: deterioration after steroid treatment and improvement with intravenous immunoglobulin. J Neurol Neurosurg Psychiatry 57: 778-783
25. Dyck PJ, Prineas J, Pollard J (1993) Chronic inflammatory demyelinating polyradiculopathy. In: Dyck PJ, Thomas PK, Griffin JW, Low PA, Poduslo JF (eds) Peripheral neuropathy. Saunders, Philadelphia, pp 1498-1517
26. Elliott JL, Pestronk A (1994) Progression of multifocal motor neuropathy during apparently successful treatment with human immunoglobulin. Neurology 44: 967-968
27. Feldman EL, Bromberg MB, Albers JW, Pestronk A (1991) Immunosuppressive treatment in multifocal motor neuropathy. Ann Neurol 30: 397-401
28. Franssen H (1996) Electrophysiological studies. In: Wokke JHJ, Latov N, Kelly J (eds) Immunological diseases of the peripheral nerve. Cambridge University Press, Cambridge (in press)
29. Franssen H, Wieneke GH, Notermans NC, Van den Berg LH (1995) Temperature dependent conduction block in peripheral neuropathy. Neuro-Orthop 17: 75-82
30. Fraser JL, Olney RK (1992) The relative diagnostic sensitivity of different F-wave parameters in various polyneuropathies. Muscle Nerve 15: 912-918
31. Gregory R, Mills K, Donaghy M (1993) Progressive sensory nerve dysfunction in amyotrophic lateral sclerosis: a prospective clinical and neurophysiological study. J Neurol 240: 309-314
32. Guijo CG, Garciamerino A, Rubio G (1995) Presence and isotype of antiganglioside antibodies in healthy persons, motor neuron disease, peripheral neuropathy, and other diseases of the nervous system. J Neuroimmunol 56: 27-33
33. Handing AE (1993) Inhereted neuronal atrophy and degeneration predomi nantly of lower motor neurons. In: Dyck PJ, Thomas PK, Griffin JW, Low PA, Poduslo JF (eds) Peripheral neuropathy. Saunders, Philadelphia, pp 1051-1064
34. Kaji R, Shibasaki H, Kimura J (1992) Multifocal demyelinating motor neuropathy: cranial nerve involvement and immunoglobulin therapy. Neurology 42: 506-509
35. Kaji R, Oka N, Tsuji T, Mezaki T, Nishio T, Akiguchi I, Kimura J (1993) Pathological findings at the site of conduction block in multifocal motor neuropathy. Ann Neurol 33: 152-158
36. Kaji R, Hirota N, Oka N, Kohara N, Watanabe T, Nishio T, Kimura J (1994) Anti-GM1 antibodies and impaired blood-nerve barrier may interfere with remyelination in multifocal motor neuropathy. Muscle Nerve 17: 108-110
37. Kaveri SV, Mouthon L, Kazatchkine MD (1994) Immunomodulating effects of intravenous immunoglobulin in autoimmune and inflammatory diseases. J Neurol Neurosurg Psychiatry [Suppl] 57: 6-8
38. Kinsella LJ, Lange DJ, Trojaborg W, Sadiq SA, Younger DS, Latov N (1994) Clinical and electrophysiological correlates of elevated anti-GM1 antibody titers. Neurology 44: 1278-1282
39. Krarup C, Stewart JD, Sumner AJ, Pestronk A, Lipton SA (1990) A syndrome of asymmetric limb weakness with motor conduction block. Neurology 40: 118-127
40. Kyle RA (1992) Monoclonal proteins in neuropathy. Neurol Clin 10: 713-734
41. Lange DJ, Trojaborg W (1994) Do GM1 antibodies induce demyelination? Muscle Nerve 17: 105-107
42. Lange DJ, Trojaborg W, Latov N, Hays AP, Younger DS, Uncini A, Blake DM, Hirano M, Burns SM, Lovelace RE, et al (1992) Multifocal motor neuropathy with conduction block: is it a distinct clinical entity? Neurology 42: 497-505
43. Lange DJ, Trojaborg W, McDonald TD, Blake DM (1993) Persistent and transient "conduction block" in motor neuron diseases. Muscle Nerve 16: 896-903
44. Layzer RB (1994) The origin of muscle fasciculations and cramps. Muscle Nerve 17: 1243-1249
45. Leger JM, Younes-Chennoufi AB, Chassande B, Davila G, Bouche P, Baumann N, Brunet P (1994) Human immunoglobulin treatment of multifocal motor neuropathy and polyneuropathy associated with monoclonal gammopathy. J Neurol Neurosurg Psychiatry [Suppl] 57:46-49
46. Leigh PN, Ray Chaudhuri K (1994) Motor neuron disease. J Neurol Neurosurg Psychiatry 57: 886-896
47. Lewis RA, Sumner AJ, Brown MJ, Asbury AK (1982) Multifocal demyelinating neuropathy with persistent conduction block. Neurology 32: 958-964
48. McCombe PA, Pollard JD, McLeod JG (1987) Chronic inflammatory demyelinating polyradiculoneuropathy. A clinical and electrophysiological study of 92 cases. Brain 110: 1617-1630
49. McLeod JG (1995) Investigation of peripheral neuropathy. J Neurol Neurosurg Psychiatry 58: 274-283
50. Nix WA (1994) Electrophysiological sequels of inflammatory demyelination. J Neurol Neurosurg Psychiatry [Suppl] 57: 29-32
51. Nobile-Orazio E, Carpo M, Legnume G. Meucci N, Sonnino S, Scarlato G (1990) Anti-GM1 IgM antibodies in motor neuron disease and neuropathy. Neurology 40: 1747-1750
52. Nobile-Orazio E, Meucci N, Barbieri S, Carpo M, Scarlato G (1993) Highdose intravenous immunoglobulin therapy in multifocal motor neuropathy. Neurology 43: 537-544
53. Ogawa Goto K, Funamoto N, Abe T, Nagashima K (1990) Different ceramide compositions of gangliosides between human motor and sensory nerves. J Neurochem 55: 1486-1493
54. Ogawa Goto K, Funamoto N, Ohta Y, Abe T, Nagashima K (1992) Myelin gangliosides of human peripheral nervous system: an enrichment of GM1 in the motor nerve myelin isolated from cauda equina. J Neurochem 59: 1844-1849
55. Oh SJ, Kim DE, Kuruoglu HR (1994) What is the best diagnostic index of conduction block and temporal dispersion? Muscle Nerve 17: 489-493
56. Oh SJ, Claussen GC, Odabasi Z, Palmer CP (1995) Multifocal demyelinating motor neuropathy: pathologicevidence of 'inflammatory demyelinating polyradiculoneuropathy'. Neurology 45: 1828-1832
57. Parry GJ (1994) Antiganglioside antibodies do not necessarily play a role in multifocal motor neuropathy. Muscle Nerve 17: 97-99
58. Parry GJ, Clarke S (1988) Multifocal acquired demyelinating neuropathy masquerading as motor neuron disease. Muscle Nerve 11: 103-107
59. Parry GJ, Sumner AJ (1992) Multifocal motor neuropathy. Neurol Clin 10: 671-684
60. Pestronk A (1991) Invited review: motor neuropathies, motor neuron disorders, and antiglycolipid antibodies. Muscle Nerve 14: 927-936
61. Pestronk A, Adams RN, Clawson L, Cornblath D, Kuncl RW, Griffin D (1988) Serum antibodies to GM1 ganglioside in amyotrophic lateral sclcrosis. Neurology 38: 1457-1461
62. Pestronk A, Cornblath DR, Ilyas AA, Baba H, Quarles RH, Griffin JW, Adams RN (1988) A treatable multifoeal motor neuropathy with antibodies to GM1 ganglioside. Ann Neurol 24: 73-78
63. Pestronk A, Chaudhry V, Feldman EL, Griffin JW, Cornblath DR, Denys EH, Glasberg M, Kuncl RW, Olney RK, Yee WC (1990) Lower motor neuron syndromes defined by patterns of weakness, nerve conduction abnormalities, and high liters of antiglycolipid antibodies. Ann Neurol 27: 316-326
64. Pestronk A, Lopate G, Kornberg AJ, Elliott JL, Blume G, Yee W-C, Goodnough LT (1994) Distal lower motor neuron syndrome with high-titer serum IgM anti-GM, antibodies: improvement following immunotherapy with monthly plasma exchange and intravenous cyclophosphamide. Neurology 44: 2027-2031
65. Rasminsky M (1973) The effects of temperature on conduction in demyelinated single nerve fibers. Arch Neurol 28: 287-292
66. Rhee EK, England JD, Suinner AJ (1990) A computer simulation of conduction block: effects produced by actual block versus interphase cancellation. Ami Neurol 28: 146-156
67. Roberts M, Willison HJ, Vincent A, Newsom Davis J (1995) Multifocal motor neuropathy human sera block distal motor nerve conduction in mice. Ann Neurol 38: 111-118
68. Roth G, Magistris MR (1987) Neuropathies with prolonged conduction block, single and grouped fasciculalions. localized limb myokymia. Electroencephalogr Clin Neurophysiol 67: 428-438
69. Sadiq SA, Thomas FP, Kilidireas K, Protopsaltis S, Hays AP, Lee KW, Kumar N, Berg L van den, Santoro M, et al (1990) The spectrum of neurologic disease associated with anti-GM1 antibodies. Neurology 40: 1067-1072
70. Santoro M, Thomas FP, Fink ME, Lange DJ, Uncini A, Wadia NH, Latov NH (1990) IgM deposits at nodes of Ranvier in a patient with amyotrophic lateral sclerosis, anti-GM1 antibodies, and multifocal motor conduction block. Ann Neurol 28: 373-377
71. Santoro M, Uncini A, Corbo M, Staugaitis SM, Thomas FP, Hays AP (1992) Experimental conduction block induced by serum from a patient with anti-GM1 antibodies. Am Neurol 31: 385-390
72. Schauf CL, Davis FA (1974) Impulse conduction in multiple sclerosis: a theoretical basis tor modification by temperature and pharmacological agents. J Neurol Neurosurg Psychiatry 37: 152-161
73. Steck AJ, Kappos L (1994) Gangliosides and autoimmune neuropathies: classification and clinical aspects of autoimmune neuropathies. J Neurol Neurosurg Psychiatry [Suppl] 57: 26-28
74. Sumner AJ (1991) Separating motor neuron diseases from pure motor neuropathies. Multifocul motor neuropathy with persistent conduction block. Adv Neurol 56: 399-403
75. + currents in isolated rat myelinated nerve fibers. Ann Neurol 37: 436-442
76. Tan E, Lynn DJ, Amato AA, Kissel JT, Rammohan KW, Sahenk Z, Warmolts JR, Jackson CE, Barohn RJ, Mendell JK (1994) Immunosuppressive treatment of motor neuron syndromes. Attempts to distinguish a treatable disorder. Arch Neurol 51: 194-200
77. Thomas FP, Trojaborg W, Nagy C, Santoro M, Sudiq SA, Latov N, Hays AP (1991) Experimental autoimmune neuropathy with anti-GM1 antibodies and immunoglobulin deposits at the nodes of Ranvier. Acta Neuropathol (Berl) 82: 378-383
78. Thomas PK, Willison HJ (1994) Motor neuropathies. In: Williams AC (ed) Motor neuron disease. Chapman & Hall, London, pp 45-81
79. Uncini A, Di Muzio A, Sabatelli M, Magi S, Tonali P, Gamhi D (1993) Sensitivity and specificity of diagnostic criteria for conduction block in chronic inflammatory demyelinating polyneuropathy. Electroencephalogr Clin Neurophysiol 89: 161-169
80. Uncini A, Santoro M, Corbo M, Lugaresi A, Latov N (1993) Conduction abnormalities induced by sera of patients with multifocal motor neuropathy and anti-GM1 antibodies. Muscle Nerve 16: 610-615
81. Valls-Solé J, Martinez AC, Graus F, Saiz A, Arpa J, Grau JM (1995) Abnormal sensory nerve conduction in multifocal demyelinating neuropathy with persistent conduction block. Neurology 45: 2024-2028
82. Van den Bergh P, Logigian EL, Kelly JJ Jr (1989) Motor neuropathy with multifocal conduction blocks. Muscle Nerve 12: 26-31
83. Van den Berg LH, Marrink J, Jager AE de, Jong HJ de, Imhoff GW van, Latov N, Sadiq SA (1992) Anti-GM1 antibodies in patients with Guillain-Barre syndrome. J Neurol Neurosurg Psychiatry 55: 8-11
84. Van den Berg LH, Franssen H, Wokke JHJ (1995) Improvement of multifocal motor neuropathy during long-term weekly treatment with high dose intravenous immunoglobulins. Neurology 45: 987-988
85. Van den Berg LH, Kerkhoff H, Oey PL, Franssen H, Mollee I, Vermeulen M, Jennekens FGI, Wokke JHJ (1995) Treatment of multifocal motor neuropathy with high-dose intravenous immunoglobulins: a double blind, placebo-controlled study. J Neurol Neurosurg Psychiatry 59: 248-252
86. Van den Berg LH, Wokke JHJ, Franssen H, Oey PL (1996) Human immunoglobulin treatment of patients with lower motor neuron disease associated with highly elevated anti-GM1 antibodies. J Neurol 243: S25, 131
87. Van der Meche FG, Schmitz PI (1992) A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barre syndrome. Dutch Guillain-Barre Study Group. N Engl J Med 326: 1123-1129
88. Van Doom PA, Brand A, Strengers PF, Meulstee J, Vermeulen M (1990) High-dose intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy: a double-blind, placebo-controlled, crossover study. Neurology 40: 209-212
89. Van Schaik IN, Vermeulen M, Brand A (1994) In vitro effects of polyvalent immunoglobulin for intravenous use. J Neurol Neurosurg Psychiatry [Suppl] 57: 15-17
90. Van Schaik IN, Vermeulen M, Van Doom PA, Brand A (1994) Anti-GM1 antibodies in patients with chronic inflammatory demyelinating polyneuropathy (CIDP) treated with intravenous immunoglobulin (IVIg). J Neuroimmunol 54: 109-115
91. Van Schaik IN, Bossuyt PMM, Brand A, Vermeulen M (1995) Diagnostic value of GM1 antibodies in motor neuron disorders and neuropathies: a metaanalysis. Neurology 45: 1570-1577
92. Windebank AJ, Bonkovsky HL (1993) Porphyric neuropathy. In: Dyck PJ, Thomas PK, Griffin JW, Low PA, Poduslo JF (eds) Peripheral neuropathy. Saunders, Philadelphia, pp 1161-1168
93. Wokke JHJ, Van den Berg LH, Franssen H, Oey PL (1996) The long-term effect of IvIg treatment in patients with MMN. Neurology 46: A381
94. Younger DS, Rowland LP, Latov N, Sherman W, Pesce M, Lange DJ, Miller JR, Lovelace RE, Hays AP, et al (1990) Motor neuron disease and amyotrophic lateral sclerosis: relation of high CSF protein content to paraproteinemia and clinical syndromes. Neurology 40: 595-599